James McKenney

785 total citations
17 papers, 652 citations indexed

About

James McKenney is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, James McKenney has authored 17 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in James McKenney's work include Erythrocyte Function and Pathophysiology (6 papers), Lipoproteins and Cardiovascular Health (6 papers) and Blood properties and coagulation (4 papers). James McKenney is often cited by papers focused on Erythrocyte Function and Pathophysiology (6 papers), Lipoproteins and Cardiovascular Health (6 papers) and Blood properties and coagulation (4 papers). James McKenney collaborates with scholars based in United States, Switzerland and Italy. James McKenney's co-authors include James A. Marcum, Robert Rosenberg, Normand L. Fortier, Narla Mohandas, L. Michael Snyder, LM Snyder, C. R. Valeri, Christie M. Ballantyne, Xavier Pintó and Evan A. Stein and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Blood.

In The Last Decade

James McKenney

17 papers receiving 617 citations

Peers

James McKenney

HEMAT

PHYSI

MB

SURGE

CB

Mary Jane Izzo United States

Samad Barzegar United States

Herbert Lau Canada

Shufang Gu United States

JW Akkerman Netherlands

Jeanny Ohan France

Ann Van Campenhout Belgium

A. P. Crockson United Kingdom

Jürgen Floege Germany

Kjell Sverre Galdal Norway

Mary Jane Izzo United States

James McKenney

125 ×0.6

HEMAT

248 ×1.4

PHYSI

187 ×1.3

MB

127 ×0.9

SURGE

64 ×0.5

CB

Citations per year, relative to James McKenney James McKenney (= 1×) peers Mary Jane Izzo

Countries citing papers authored by James McKenney

Since Specialization

Citations

This map shows the geographic impact of James McKenney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James McKenney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James McKenney more than expected).

Fields of papers citing papers by James McKenney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James McKenney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James McKenney. The network helps show where James McKenney may publish in the future.

Co-authorship network of co-authors of James McKenney

This figure shows the co-authorship network connecting the top 25 collaborators of James McKenney. A scholar is included among the top collaborators of James McKenney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James McKenney. James McKenney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Thompson, Paul D., Christie M. Ballantyne, James McKenney, et al.. (2015). ETC-1002 LOWERS LDL-C MORE THAN EZETIMIBE IN PATIENTS WITH HYPERCHOLESTEROLEMIA WITH OR WITHOUT STATIN INTOLERANCE AND HAS A SIMILAR SAFETY AND TOLERABILITY PROFILE. Journal of the American College of Cardiology. 65(10). A1349–A1349. 5 indexed citations

2.

Koren, Michael J., Evan A. Stein, Eli M. Roth, et al.. (2013). Efficacy, Safety and Tolerability of Alirocumab 150 mg Q2W, a Fully Human PCSK9 Monoclonal Antibody: A Pooled Analysis of 352 Patients from Phase 2. Journal of clinical lipidology. 7(3). 279–280. 4 indexed citations

3.

Gaudet, Daniel, Dean J. Kereiakes, James McKenney, et al.. (2013). Alirocumab, a Fully Human Monoclonal Antibody to PCSK9, Reduces High Plasma Lp(a) Concentration: Pooled Analysis of 352 Patients from Phase 2. Journal of clinical lipidology. 7(3). 283–284. 5 indexed citations

4.

Roth, Eli M., James McKenney, Corinne Hanotin, Gaëlle Asset, & Evan A. Stein. (2012). THE EFFECTS OF CO-ADMINISTERING A MONOCLONAL ANTIBODY TO PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 SERINE PROTEASE, REGN727/SAR236553, WITH 10 AND 80 MG ATORVASTATIN COMPARED TO 80 MG ATORVASTATIN ALONE IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA (NCT: 01288469). Journal of the American College of Cardiology. 59(13). E1620–E1620. 1 indexed citations

5.

Bays, Harold, James McKenney, Ralph T. Doyle, Roderick N. Carter, & Evan A. Stein. (2008). Abstract 5150: Effect of Prescription Omega-3 Fatty Acids Coadministered with Escalating Doses of Atorvastatin in Patients with Hypertriglyceridemia. Circulation. 118. 3 indexed citations

6.

Kiefer, Charles R., et al.. (2002). Maturation-Dependent Acquired Coronary Structural Alterations and Atherogenesis in the Dahl Sodium-Sensitive Hypertensive Rat. Circulation. 106(19). 2486–2490. 4 indexed citations

7.

Ballantyne, Christie M., Franco Pazzucconi, Xavier Pintó, et al.. (2001). Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis. Clinical Therapeutics. 23(2). 177–192. 65 indexed citations

8.

Kiefer, Charles R., James McKenney, Herbert L. Bonkovsky, et al.. (1998). Porphyrin Loading of Lipofuscin Granules in Inflamed Striated Muscle. American Journal Of Pathology. 153(3). 703–708. 7 indexed citations

9.

Lieberthal, Wilfred, et al.. (1997). Beta1 integrin-mediated adhesion between renal tubular cells after anoxic injury.. Journal of the American Society of Nephrology. 8(2). 175–183. 33 indexed citations

10.

Waugh, Richard E., et al.. (1997). Surface area and volume changes during maturation of reticulocytes in the circulation of the baboon. Journal of Laboratory and Clinical Medicine. 129(5). 527–535. 45 indexed citations

11.

McKenney, James, et al.. (1990). Decreased in vivo survival of hydrogen peroxide-damaged baboon red blood cells. Blood. 76(1). 206–211. 17 indexed citations

12.

McKenney, James, et al.. (1990). Decreased in vivo survival of hydrogen peroxide-damaged baboon red blood cells. Blood. 76(1). 206–211. 30 indexed citations

13.

Fortier, Normand L., et al.. (1988). The relationship between in vivo generated hemoglobin skeletal protein complex and increased red cell membrane rigidity. Blood. 71(5). 1427–1431. 6 indexed citations

14.

Snyder, L. Michael, Normand L. Fortier, Laszlo Leb, et al.. (1988). The role of membrane protein sulfhydryl groups in hydrogen peroxide-mediated membrane damage in human erythrocytes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 937. 229–240. 54 indexed citations

15.

Fortier, Normand L., et al.. (1988). The relationship between in vivo generated hemoglobin skeletal protein complex and increased red cell membrane rigidity. Blood. 71(5). 1427–1431. 70 indexed citations

16.

Marcum, James A., James McKenney, SJ Galli, Robert W. Jackman, & R D Rosenberg. (1986). Anticoagulantly active heparin-like molecules from mast cell-deficient mice. American Journal of Physiology-Heart and Circulatory Physiology. 250(5). H879–H888. 31 indexed citations

17.

Marcum, James A., James McKenney, & Robert Rosenberg. (1984). Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.. Journal of Clinical Investigation. 74(2). 341–350. 272 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact